The inflammatory transcription factor STAT3 collaborated with NF-κB and acted on the FAT10 promoter and then induced FAT10 gene expression, resulting in increased FAT10 expression in inflammation-related cancer types 22, 24, 38. This evidence concerns the gene STAT3 and cancer.